Bausch Health Cos., Inc. (BHC.TO)
8.64
+0.04
(+0.47%)
CAD |
TSX |
Oct 09, 16:00
Bausch Health Cos. Price : 8.64 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 8.59 | 8.81 | 8.59 | 8.64 | 252511.0 |
| Oct 08, 2026 | 8.73 | 8.81 | 8.56 | 8.60 | 328991.0 |
| Oct 07, 2026 | 8.57 | 9.015 | 8.57 | 8.79 | 418130.0 |
| Oct 06, 2026 | 8.40 | 8.68 | 8.295 | 8.56 | 813367.0 |
| Oct 05, 2026 | 8.26 | 8.50 | 8.20 | 8.42 | 298313.0 |
| Oct 02, 2026 | 8.15 | 8.36 | 7.99 | 8.27 | 570195.0 |
| Oct 01, 2026 | 8.28 | 8.36 | 8.06 | 8.13 | 481016.0 |
| Sep 30, 2026 | 8.17 | 8.41 | 8.12 | 8.29 | 425653.0 |
| Sep 29, 2026 | 8.14 | 8.22 | 8.065 | 8.20 | 327335.0 |
| Sep 28, 2026 | 8.03 | 8.27 | 7.94 | 8.20 | 334474.0 |
| Sep 25, 2026 | 8.01 | 8.25 | 7.95 | 8.06 | 428313.0 |
| Sep 24, 2026 | 8.00 | 8.17 | 7.835 | 7.97 | 802964.0 |
| Sep 23, 2026 | 8.21 | 8.345 | 8.00 | 8.04 | 969244.0 |
| Sep 22, 2026 | 7.91 | 8.20 | 7.90 | 8.17 | 549213.0 |
| Sep 21, 2026 | 7.97 | 7.99 | 7.79 | 7.93 | 394567.0 |
| Sep 18, 2026 | 7.95 | 8.015 | 7.86 | 7.92 | 843149.0 |
| Sep 17, 2026 | 8.08 | 8.08 | 7.88 | 7.92 | 581690.0 |
| Sep 16, 2026 | 7.91 | 8.125 | 7.88 | 7.98 | 548272.0 |
| Sep 15, 2026 | 8.15 | 8.20 | 7.85 | 7.88 | 505110.0 |
| Sep 14, 2026 | 8.10 | 8.42 | 8.10 | 8.25 | 395925.0 |
| Sep 11, 2026 | 8.45 | 8.45 | 8.09 | 8.10 | 665687.0 |
| Sep 10, 2026 | 8.45 | 8.52 | 8.12 | 8.42 | 370960.0 |
| Sep 09, 2026 | 8.82 | 8.90 | 8.48 | 8.50 | 542362.0 |
| Sep 08, 2026 | 9.06 | 9.19 | 8.835 | 8.86 | 423635.0 |
| Sep 04, 2026 | 9.32 | 9.32 | 9.03 | 9.06 | 228247.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 4.09 |
| Cipher Pharmaceuticals, Inc. | 13.65 |
| BioSyent, Inc. | 17.15 |
| Revive Therapeutics Ltd. | 0.025 |
| Knight Therapeutics, Inc. | 10.83 |
Price Related Metrics
| PS Ratio | 0.2155 |
| Price to Free Cash Flow | 1.687 |
| Earnings Yield | -46.95% |
| Market Cap | 3.231B |
| Operating PE Ratio | 0.856 |
| Normalized PE Ratio | 11.31 |